当前位置:首页 - 行情中心 - 小方制药(603207) - 财务分析 - 现金流量表

小方制药

(603207)

  

流通市值:12.38亿  总市值:36.68亿
流通股本:5460.29万   总股本:1.62亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金490,172,227.59311,313,497.45152,687,702.87562,228,319.24
  收到的税费返还3,024,551.463,024,551.46-2,237,093.21
  收到其他与经营活动有关的现金1,066,069.59456,086.932,134,423.831,575,392.68
  经营活动现金流入小计494,262,848.64314,794,135.84154,822,126.7566,040,805.13
  购买商品、接受劳务支付的现金158,188,441.61105,703,886.4559,176,695.59191,833,932.62
  支付给职工以及为职工支付的现金66,491,572.9645,847,810.7222,350,597.7880,796,240.2
  支付的各项税费61,307,510.7942,449,107.3518,885,091.9988,358,064.71
  支付其他与经营活动有关的现金36,268,422.4123,058,054.499,078,514.7444,255,918.12
  经营活动现金流出小计322,255,947.77217,058,859.01109,490,900.1405,244,155.65
  经营活动产生的现金流量净额172,006,900.8797,735,276.8345,331,226.6160,796,649.48
二、投资活动产生的现金流量:
  收回投资收到的现金421,144,000147,000,0003,000,000923,000,000
  取得投资收益收到的现金3,500,597.022,281,5001,730,208.334,138,663.88
  处置固定资产、无形资产和其他长期资产收回的现金净额---110,619.47
  投资活动现金流入小计424,644,597.02149,281,5004,730,208.33927,249,283.35
  购建固定资产、无形资产和其他长期资产支付的现金66,593,467.9661,620,231.1956,097,176.7854,240,215.64
  投资支付的现金666,288,000324,144,000303,000,000567,000,000
  投资活动现金流出小计732,881,467.96385,764,231.19359,097,176.78621,240,215.64
  投资活动产生的现金流量净额-308,236,870.94-236,482,731.19-354,366,968.45306,009,067.71
三、筹资活动产生的现金流量:
  吸收投资收到的现金16,544,294.411,446,777.153,320,621.418,382,705.99
  收到其他与筹资活动有关的现金12,167,886.337,662,756.66,354,357.21,119,069.58
  筹资活动现金流入小计28,712,180.749,109,533.759,674,978.619,501,775.57
  分配股利、利润或偿付利息支付的现金59,463,062.5719,725,031.12-353,231,927.4
  支付其他与筹资活动有关的现金2,912,801.91291,00040,5005,735,820
  筹资活动现金流出小计62,375,864.4820,016,031.1240,500358,967,747.4
  筹资活动产生的现金流量净额-33,663,683.74-10,906,497.379,634,478.61-349,465,971.83
五、现金及现金等价物净增加额-169,893,653.81-149,653,951.73-299,401,263.24117,339,745.36
  加:期初现金及现金等价物余额544,189,596.35544,189,596.35544,189,596.35426,849,850.99
  期末现金及现金等价物余额374,295,942.54394,535,644.62244,788,333.11544,189,596.35
补充资料:
  净利润-105,550,017.8-207,489,677.18
  资产减值准备-498.86-183,048.19
  固定资产和投资性房地产折旧-1,223,139.5-1,928,961.94
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,223,139.5-1,928,961.94
  无形资产摊销-793,794.78-9,350.76
  长期待摊费用摊销---99,144.12
  递延收益摊销----12,857.16
  处置固定资产、无形资产和其他长期资产的损失-5,641.59--110,619.47
  财务费用--1,869,805.94--532,028.58
  递延所得税--329,407.45--1,321,536.72
  其中:递延所得税资产减少--322,978.87--1,321,536.72
    递延所得税负债增加--6,428.58--
  存货的减少-7,799,700.77--24,161,113.86
  经营性应收项目的减少--11,382,618.92--48,716,490.55
  经营性应付项目的增加--6,327,300.72-20,425,168.79
  现金的期末余额-394,535,644.62-544,189,596.35
  减:现金的期初余额-544,189,596.35-426,849,850.99
  现金及现金等价物的净增加额--149,653,951.73-117,339,745.36
公告日期2026-10-242026-08-272026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑